Dr. Sameer Tulpule is a highly accomplished hematologist and bone marrow transplant specialist with extensive international and Indian experience. He has trained and worked in leading institutions in the UK, including Nottingham University Hospitals and Sheffield Teaching Hospitals, before moving back to India to advance transplant medicine. He has been instrumental in developing advanced therapies like CAR-T Cell Therapy and has handled complex transplant cases with high success. His compassionate approach, patient-centric care, and global expertise make him one of the most sought-after hematology specialists in Mumbai.

Educational Qualifications:

• FRCPath – Royal College of Pathologists, UK (2011)
• MRCP – Royal College of Physicians, UK (2004)
• MD (Medicine) – JNMC & KLES Hospital, RGUHS, Bangalore (1999)
• MBBS – Seth G.S. Medical College & K.E.M. Hospital, Mumbai (1993)

Professional Experience:

• Senior Director – Haematology & BMT, Nanavati Max Super Speciality Hospital, Mumbai (2025 – Present)
• Consultant – Haematology & Stem Cell Transplantation, Kokilaben Dhirubhai Ambani Hospital, Mumbai (2015 – 2025)
• Consultant – Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, UK (2013 – 2015)
• Fellow (Post-CCT) – Bone Marrow Transplant, Nottingham University Hospitals NHS Trust, UK (2013)
• Locum Consultant – Haematology, Northwick Park Hospital, London (2012 – 2013)
• Research Fellow – Stem Cell Transplant, Anthony Nolan Trust, London (2009 – 2011)

Awards & Achievements:

• “Best Outgoing Resident” in Medicine – 4th Karnataka State Conference, API & CSI
• University Distinctions in Pathology & Pharmacology
• Second Rank in MBBS, University of Bombay

Professional Memberships:

• Indian Society of Haematology & Blood Transfusion (ISHBT)
• British Society of Haematology (BSH)
• American Society of Hematology (ASH)
• European Society for Blood & Marrow Transplantation (EBMT)

Research & Publications:

• Rejection of Paternal vs Maternal Fully Matched Bone Marrow Grafts in Children with Thalassaemia (2017)
• Graft Versus Host Disease in HSCT – UK Multicentre Study (2015)
• Immune Reconstitution in Cord Blood Transplantation – CML, Leukemia & Lymphoma (2011)
• Severe Allergic Reaction to G-CSF (Lenograstim) in Healthy Donor (2009)
• Pregnancy Outcomes in Idiopathic Myelofibrosis – Br J Haematol (2008)
• PCR Assay for Donor Chimerism in HSCT – Can J Biotechnol (2017)